These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2627135)

  • 1. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. II. Pathological studies.
    Madarnas P; Benrezzak O; Pageau R; Nigam VN; Elhilali M
    Anticancer Res; 1989; 9(6):1889-95. PubMed ID: 2627135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN; Elhilali MM
    Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O; Bissonnette E; Madarnas P; Nigam VN
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antiangiogenic tumor treatment.
    Madarnas P; Benrezzak O; Nigam VN
    Anticancer Res; 1989; 9(4):897-901. PubMed ID: 2479330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM; Joseph WR; Baguley BC
    Anticancer Res; 1993; 13(4):1139-41. PubMed ID: 8352536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.
    Penhaligon M; Camplejohn RS
    J Natl Cancer Inst; 1985 Apr; 74(4):869-73. PubMed ID: 3857381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
    Nigam VN; Brière N; Bonaventure J; Pageau R; Bissonnette E; Brailovsky C; Madarnas P
    Anticancer Res; 1986; 6(2):245-50. PubMed ID: 3085575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
    Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
    Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antitumor immunity employing live tumor cells and maltose tetrapalmitate.
    Bonaventure J; Nigam VN; Brailovsky CA
    J Biol Response Mod; 1985 Jun; 4(3):258-63. PubMed ID: 4020385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung deposits.
    Milas L; Hunter N; Basic I
    Clin Exp Metastasis; 1985; 3(4):247-55. PubMed ID: 4075612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maltose tetrapalmitate, a nontoxic immunopotentiator with antitumor activity.
    Nigam VN; Brailovsky CA; Chopra C
    Cancer Res; 1978 Oct; 38(10):3315-21. PubMed ID: 688221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
    Ching LM; Joseph WR; Baguley BC
    Anticancer Res; 1993; 13(6A):2069-75. PubMed ID: 8297115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
    Schirner M; Schneider MR
    Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study].
    Flores JM; Gallego E; Castaño M; González JL
    Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of the anticoagulants heparin and warfarin on newly implanted and two week old C3H/HeJ mouse mammary tumor implants.
    Knapp K; Deweese-Mays J; Kim E; Curry G; Littlejohn M; Romeo D; Ryono R; Lawyer K; Schindler J; Zelman M
    Proc West Pharmacol Soc; 1983; 26():421-5. PubMed ID: 6889374
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.